Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal throm
- PDF / 3,703,559 Bytes
- 18 Pages / 595.276 x 790.866 pts Page_size
- 109 Downloads / 173 Views
Journal of Translational Medicine Open Access
RESEARCH
Mass spectrometry‑based analysis of formalin‑fixed, paraffin‑embedded distal cholangiocarcinoma identifies stromal thrombospondin‑2 as a potential prognostic marker Johannes Byrling1, Theresa Kristl2, Dingyuan Hu1, Indira Pla2, Aniel Sanchez2, Agata Sasor3, Roland Andersson1, György Marko‑Varga2 and Bodil Andersson1*
Abstract Background: Distal cholangiocarcinoma is an aggressive malignancy with a dismal prognosis. Diagnostic and prog‑ nostic biomarkers for distal cholangiocarcinoma are lacking. The aim of the present study was to identify differentially expressed proteins between distal cholangiocarcinoma and normal bile duct samples. Methods: A workflow utilizing discovery mass spectrometry and verification by parallel reaction monitoring was used to analyze surgically resected formalin-fixed, paraffin-embedded samples from distal cholangiocarcinoma patients and normal bile duct samples. Bioinformatic analysis was used for functional annotation and pathway analysis. Immunohistochemistry was performed to validate the expression of thrombospondin-2 and investigate its association with survival. Results: In the discovery study, a total of 3057 proteins were identified. Eighty-seven proteins were found to be differentially expressed (q
Data Loading...
